Introducing the revolutionary sleep apnea implant Enter the game-changing implant technology that’s transforming sleep apnea treatment. Two notable options have emerged: Genio Nyxoah and Inspire.

Try a single issue or save on a subscription Issues delivered straight to your door or device ...

WAKE-UP CALL: 104m Indians or 11% of the population suffer from obstructive sleep apnea, according to a 2023 AIIMS study ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment, with FDA approval expected in Q1 2025 acting as a potential catalyst for shares. Nyxoah, founded by Robert Taub ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

Dec. 18, 2024 — People with breathing problems during sleep may have a larger hippocampus, the area of the brain responsible for memory and thinking, according to a new study. The study, which ...